1. Mentzel T, Pedeutour F, Lazar AJF et al. Dermatofibrosarcoma protuberans In: Fletcher CDM, Bridge JA, Hogendoorn PCW, (eds) World Health Organisation Classification of Tumours of Soft Tissue and Bone. IARC Press: Lyon, France, 2013, pp 77–79.
2. Liu LS, Colegio OR . Molecularly targeted therapies for nonmelanoma skin cancers. Int J Dermatol 2013;52:654–665.
3. Rubin BP, Schuetze SM, Eary JF et al. Molecular targeting of platelet-derived growth factor B by imatinib mesylate in a patient with metastatic dermatofibrosarcoma protuberans. J Clin Oncol 2002;20:3586–3591.
4. Weiss S, Goldblum JR . Dermatofibrosarcoma protuberans In: Weiss SW, Goldblum JR, (eds) Enzinger and Weiss's Soft Tissue Tumors. Mosby: St Louis, MO, USA, 2008, pp 371–382.
5. Pedeutour F, Simon MP, Minoletti F et al. Ring 22 chromosomes in dermatofibrosarcoma protuberans are low-level amplifiers of chromosome 17 and 22 sequences. Cancer Res 1995;55:2400–2403.